Search for: "In re: Farxiga (Dapagliflozin) Products Liability Litigation"
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
12 May 2017, 9:05 am
On April 6, 2017 the United States Judicial Panel On Multidistrict Litigation (JPML) issued this document, "IN RE: FARXIGA (DAPAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION TRANSFER ORDER -- MDL No. 2776", from which we get the following information: The eighteen actions involve allegations that ingestion of the drug Farxiga may cause a variety of injuries, including diabetic ketoacidosis and kidney damage, and that… [read post]
21 Feb 2018, 1:40 pm
IN RE: Farxiga (Dapagliflozin) Products Liability Litigation MDL-2776 Number of lawsuits pending: 51 Diabetes drugs in this MDL case: Farxiga (dapagliflozin) Xigduo XR (dapagliflozin and metformin extended-release) Qtern (dapagliflozin and saxagliptin) Primary side effects for these cases: Diabetic Ketoacidosis (DKA) Ketoacidosis Ketosis Get more information about these drug… [read post]
